Search results
FDA Approval of Alvotech/Teva Ustekinumab Biosimilar | JD Supra
JD Supra· 2 days agoOn April 16, Alvotech and Teva announced the FDA approval of SELARSDI™ (ustekinumab-aekn), biosimilar to Johnson and Johnson’s STELERA® (ustekinumab). The product was approved as a subcutaneous ...
Gout in Elbow Symptoms
Verywell Health via Yahoo News· 2 days agoPeople assigned male at birth—especially those between ages 30 and 45—and those assigned female at birth who are between ages 55 and 70 are at an...
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit...
Morningstar· 12 hours agoLOS ANGELES, April 24, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 30, 2024 deadline to file a lead plaintiff motion in the class action filed on behalf of Ventyx Biosciences, Inc. (“Ventyx” or
Here Are the 15 Best Moisturizers to Try If You Have Dry Skin
Harper's Bazaar via Yahoo News· 6 days agoRenewal Night Cream If you like instant—or more accurately, overnight—results, consider this ...
Can-Fite BioPharma (NYSE:CANF) Receives New Coverage from Analysts at StockNews.com
ETF DAILY NEWS· 2 days agoStockNews.com began coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report released on Monday. The brokerage issued a hold rating on the stock. Can-Fite BioPharma ...
MDs Share the Menopause Skin Care Routine + Products for Women Over 50 To Smooth Wrinkles, Hydrate...
Woman's World via Yahoo News· 16 hours ago“Incorporating chemical exfoliants like glycolic acid to support turnover from the top down by...
Rand Stages Recovery from Recent Beating
Investing.com· 19 hours agoAmong individual stocks, Capitec (JO: CPIJ ) led the gains with an increase of over 7.79%, buoyed by strong financial results for the fiscal year ending...
Novartis Raises Guidance on Profit, Sales Growth
The Wall Street Journal· 2 days agoNovartis lifted its full-year guidance after first-quarter profit and sales rose and beat consensus expectations, boosted by strong sales of key drugs.
MoonLake Immunotherapeutics (NASDAQ:MLTX) Stock Rating Reaffirmed by HC Wainwright
ETF DAILY NEWS· 4 hours agoMoonLake Immunotherapeutics (NASDAQ:MLTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research report issued to clients and investors on Tuesday ...
15 Celebrities Who Faced Rare or Chronic Illnesses: From Ashton Kutcher's Autoimmune Vasculitis to...
RadarOnline.com· 4 days agoAshton Kutcher went public with his battle with a debilitating autoimmune disease, vasculitis, in...
